UPDATE: B.Riley Downgrades Madrigal Pharmaceuticals (MDGL) to Neutral
Tweet Send to a Friend
(Updated - July 8, 2022 4:59 AM EDT)
B.Riley analyst Mayank Mamtani downgraded Madrigal Pharmaceuticals (NASDAQ: MDGL) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Mayank Mamtani downgraded Madrigal Pharmaceuticals (NASDAQ: MDGL) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
